Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Mustafa Çoban, Uğur Bilge, Hale Balseven, Hilmi Uysal & Betül Artut. (2023) The economic evaluation of ALS care: quality and cost. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 502-513.
Read now
Read now
James D. Berry, Marie Blanchard, Kerina Bonar, Emma Drane, Molly Murton, Uffe Ploug, Kristen Ricchetti-Masterson, Natasa Savic, Emma Worthington & Terry Heiman-Patterson. (2023) Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 436-448.
Read now
Read now
Toni Mora, Raúl Domínguez, Abdelilah Assialioui, Andrés Paipa, Ramon Moreno, Xavier Corbella, Antonio Martínez-Yelamos & Mònica Povedano. (2023) Direct health costs of amyotrophic lateral sclerosis in a multidisciplinary ALS unit in Catalonia (Spain). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 133-138.
Read now
Read now
Nicole Peters, Vanina Dal Bello-Haas, Tara Packham, Marvin Chum, Colleen O’Connell, Wendy S Johnston, Joy C MacDermid, John Turnbull, Jill Van Damme & Ayse Kuspinar. (2021) Do Generic Preference-Based Measures Accurately Capture Areas of Health-Related Quality of Life Important to Individuals with Amyotrophic Lateral Sclerosis: A Content Validation Study. Patient Related Outcome Measures 12, pages 191-203.
Read now
Read now
Nilda Turgut, Gamze Varol SaraÇoglu, Selahattin Kat, Kemal Balci, BabÜrhan GÜldiken, Ozlem Birgili & Levent Kabayel. (2019) An epidemiologic investigation of amyotrophic lateral sclerosis in Thrace, Turkey, 2006–2010*. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 100-106.
Read now
Read now
Priya Treesa Thomas, Manjusha G. Warrier, Arun Sadasivan, Bhuvaneshwari Balasubramanium, Veeramani Preethish-kumar, Saraswati Nashi, Kiran Polavarapu, Gopalkrishna Krishna, Seena Vengalil, Prakashi Rajaram & Atchayaram Nalini. (2018) Caregiver burden and quality of life of patients with amyotrophic lateral sclerosis in India. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 606-610.
Read now
Read now
Lisa Meng, Amy Bian, Scott Jordan, Andrew Wolff, Jeremy M. Shefner & Jinsy Andrews. (2018) Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 134-142.
Read now
Read now
Anne Hogden, Geraldine Foley, Robert D Henderson, Natalie James & Samar M Aoun. (2017) Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. Journal of Multidisciplinary Healthcare 10, pages 205-215.
Read now
Read now
Kevin Boylan, Todd Levine, Catherine Lomen-Hoerth, Mary Lyon, Kimberly Maginnis, Peter Callas, Celeste Gaspari & Rup Tandan. (2016) Prospective study of cost of care at multidisciplinary ALS centers adhering to American Academy of Neurology (AAN) ALS practice parameters. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 119-127.
Read now
Read now
M. Felícitas Domínguez-berjón, María D. Esteban-Vasallo, Ana Clara Zoni, Ricard Gènova-Maleras & Jenaro Astray-Mochales. (2016) Place of death and associated factors among patients with amyotrophic lateral sclerosis in Madrid (Spain). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 62-68.
Read now
Read now
Matthew Gladman & Lorne Zinman. (2015) The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 15:3, pages 439-450.
Read now
Read now
Juyeon Oh, Ji Won An, Seong-Il Oh, Ki Wook Oh, Jung A Kim, Jeong Seop Lee & Seung Hyun Kim. (2015) Socioeconomic costs of amyotrophic lateral sclerosis according to staging system. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:3-4, pages 202-208.
Read now
Read now
Kostas Athanasakis, Ilias-Ioannis Kyriopoulos, Manthos Sideris, Michael Rentzos, John Evdokimidis & John Kyriopoulos. (2015) Investigating the economic burden of ALS in Greece: A cost-of-illness approach. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:1-2, pages 63-64.
Read now
Read now
Matthew Gladman, Celina Dharamshi & Lorne Zinman. (2014) Economic burden of amyotrophic lateral sclerosis: A Canadian study of out-of-pocket expenses. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 426-432.
Read now
Read now
Ali Aamer Habib & Hiroshi Mitsumoto. (2011) Emerging drugs for amyotrophic lateral sclerosis. Expert Opinion on Emerging Drugs 16:3, pages 537-558.
Read now
Read now
Articles from other publishers (42)
Julien Delaye, Pasquale Cacciatore & Anna Kole. (2022) Valuing the “Burden” and Impact of Rare Diseases: A Scoping Review. Frontiers in Pharmacology 13.
Crossref
Crossref
Francesco Saverio MENNINI & Lara GITTO. (2022) APPROACHES TO ESTIMATING INDIRECT COSTS IN HEALTHCARE: MOTIVATIONS FOR CHOICE. JOURNAL OF EUROPEAN ECONOMY:Volume 21, Vol 21, No 1 (2022), pages 17-45.
Crossref
Crossref
Hoda S. Abdel Magid, Barbara Topol, Valerie McGuire, Jessica A. Hinman, Edward J. Kasarskis & Lorene M. Nelson. (2022) Cardiovascular Diseases, Medications, and ALS: A Population-Based Case-Control Study. Neuroepidemiology 56:6, pages 423-432.
Crossref
Crossref
Lidia García-Pérez, Renata Linertová, Cristina Valcárcel-Nazco, Manuel Posada, Inigo Gorostiza & Pedro Serrano-Aguilar. (2021) Cost-of-illness studies in rare diseases: a scoping review. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Suzanne F. Cook, Thomas Rhodes, Courtney Schlusser, Steve Han, Chao Chen, Neta Zach, Venkatesha Murthy & Shreya Davé. (2021) A Descriptive Review of Global Real World Evidence Efforts to Advance Drug Discovery and Clinical Development in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 12.
Crossref
Crossref
K. Achtert & L. Kerkemeyer. (2021) The economic burden of amyotrophic lateral sclerosis: a systematic review. The European Journal of Health Economics 22:8, pages 1151-1166.
Crossref
Crossref
Alec S. T. Smith, Changho Chun, Jennifer Hesson, Julie Mathieu, Paul N. Valdmanis, David L. Mack, Byung-Ok Choi, Deok-Ho Kim & Mark Bothwell. (2021) Human Induced Pluripotent Stem Cell-Derived TDP-43 Mutant Neurons Exhibit Consistent Functional Phenotypes Across Multiple Gene Edited Lines Despite Transcriptomic and Splicing Discrepancies. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Alicia Aurora Rodríguez, Óscar Martínez, Imanol Amayra, Juan Francisco López-Paz, Mohammad Al-Rashaida, Esther Lázaro, Patricia Caballero, Manuel Pérez, Sarah Berrocoso, Maitane García, Paula María Luna, Paula Pérez-Núñez & Nicole Passi. (2021) Diseases Costs and Impact of the Caring Role on Informal Carers of Children with Neuromuscular Disease. International Journal of Environmental Research and Public Health 18:6, pages 2991.
Crossref
Crossref
Nicole Peters, Vanina Dal Bello-Haas, Tara Packham, Ava Mehdipour & Ayse Kuspinar. (2021) Psychometric Properties of Preference-Based Measures for Economic Evaluation in Amyotrophic Lateral Sclerosis: A Systematic Review. Neurology Research International 2021, pages 1-13.
Crossref
Crossref
Erik Schönfelder, Alma Osmanovic, Lars Hendrik Müschen, Susanne Petri & Olivia Schreiber-Katz. (2020) Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Gabriela M. Stegmann, Shira Hahn, Julie Liss, Jeremy Shefner, Seward Rutkove, Kerisa Shelton, Cayla Jessica Duncan & Visar Berisha. (2020) Early detection and tracking of bulbar changes in ALS via frequent and remote speech analysis. npj Digital Medicine 3:1.
Crossref
Crossref
Luz María Peña-Longobardo, Isaac Aranda-Reneo, Juan Oliva-Moreno, Svenja Litzkendorf, Isabelle Durand-Zaleski, Eduardo Tizzano & Julio López-Bastida. (2020) The Economic Impact and Health-Related Quality of Life of Spinal Muscular Atrophy. An Analysis across Europe. International Journal of Environmental Research and Public Health 17:16, pages 5640.
Crossref
Crossref
Clare Cheng, John P Hirdes, George Heckman & Jeff Poss. (2020) Predictors of Home Care Costs Among Persons With Dementia, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis in Ontario. Health Services Insights 13, pages 117863292090373.
Crossref
Crossref
Josep Darbà. (2019) Current status and direct medical cost of amyotrophic lateral sclerosis in the region of Catalonia: A population-based analysis. PLOS ONE 14:10, pages e0223772.
Crossref
Crossref
Mika L Nonoyama, Douglas A McKim, Jeremy Road, Denise Guerriere, Peter C Coyte, Marina Wasilewski, Monica Avendano, Sherri L Katz, Reshma Amin, Roger Goldstein, Brandon Zagorski & Louise Rose. (2018) Healthcare utilisation and costs of home mechanical ventilation. Thorax 73:7, pages 644-651.
Crossref
Crossref
Anne Hogden & Ashley Crook. (2017) Patient-centered decision making in amyotrophic lateral sclerosis: where are we?. Neurodegenerative Disease Management 7:6, pages 377-386.
Crossref
Crossref
Julio López-Bastida, Luz María Peña-Longobardo, Isaac Aranda-Reneo, Eduardo Tizzano, Mark Sefton & Juan Oliva-Moreno. (2017) Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain. Orphanet Journal of Rare Diseases 12:1.
Crossref
Crossref
R. Spataro, P. Volanti, D. Lo Coco & V. La Bella. (2017) Marital status is a prognostic factor in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 136:6, pages 624-630.
Crossref
Crossref
Julio López-Bastida, Juan Pedro López-Siguero, Juan Oliva-Moreno, Magaly Perez-Nieves, Renata Villoro, Tatiana Dilla, María Merino, Dingfeng Jiang, Isaac Aranda-Reneo, Jesús Reviriego & Luis Alberto Vázquez. (2017) Social economic costs of type 1 diabetes mellitus in pediatric patients in Spain: CHRYSTAL observational study. Diabetes Research and Clinical Practice 127, pages 59-69.
Crossref
Crossref
C.R. Sánchez-López, L. Perestelo-Pérez, A. Escobar, J. López-Bastida & P. Serrano-Aguilar. (2017) Health-related quality of life in patients with spinocerebellar ataxia. Neurología (English Edition) 32:3, pages 143-151.
Crossref
Crossref
C.R. Sánchez-López, L. Perestelo-Pérez, A. Escobar, J. López-Bastida & P. Serrano-Aguilar. (2017) Calidad de vida relacionada con la salud en pacientes con ataxias espinocerebelosas. Neurología 32:3, pages 143-151.
Crossref
Crossref
Alan Moore, Carolyn A. Young & Dyfrig A. Hughes. (2016) Economic Studies in Motor Neurone Disease: A Systematic Methodological Review. PharmacoEconomics 35:4, pages 397-413.
Crossref
Crossref
Rachel McCormick & Katarzyna Goljanek-Whysall. 2017. MiRNAs in Aging and Cancer. MiRNAs in Aging and Cancer
265
308
.
J. Gamez, M. Salvado, A. Martínez de la Ossa & M. Badia. (2016) Lithium for treatment of amyotrophic lateral sclerosis: Much ado about nothing. Neurología (English Edition) 31:8, pages 550-561.
Crossref
Crossref
J. Gamez, M. Salvado, A. Martínez de la Ossa & M. Badia. (2016) Litio para el tratamiento de la esclerosis lateral amiotrófica: mucho ruido para nada. Neurología 31:8, pages 550-561.
Crossref
Crossref
Karissa C. Arthur, Andrea Calvo, T. Ryan Price, Joshua T. Geiger, Adriano Chiò & Bryan J. Traynor. (2016) Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nature Communications 7:1.
Crossref
Crossref
Hongjie Wang, Ruizhi Wang, Shaohua Xu & Madepalli K. Lakshmana. (2016) Transcription Factor EB Is Selectively Reduced in the Nuclear Fractions of Alzheimer’s and Amyotrophic Lateral Sclerosis Brains. Neuroscience Journal 2016, pages 1-8.
Crossref
Crossref
Julio López-Bastida, Juan Oliva-Moreno, Renata Linertová & Pedro Serrano-Aguilar. (2016) Social/economic costs and health-related quality of life in patients with rare diseases in Europe. The European Journal of Health Economics 17:S1, pages 1-5.
Crossref
Crossref
Lorenza Magliano, Melania Patalano, Alessandra Sagliocchi, Marianna Scutifero, Antonella Zaccaro, Maria Grazia D'angelo, Federica Civati, Erika Brighina, Giuseppe Vita, Gian Luca Vita, Sonia Messina, Maria Sframeli, Marika Pane, Maria Elena Lombardo, Roberta Scalise, Adele D'amico, Giulia Colia, Michela Catteruccia, Umberto Balottin, Angela Berardinelli, Maria Chiara Motta, Corrado Angelini, Alessandra Gaiani, Claudio Semplicini, Luca Bello, Roberta Battini, Guja Astrea & Luisa Politano. (2015) Burden, professional support, and social network in families of children and young adults with muscular dystrophies. Muscle & Nerve 52:1, pages 13-21.
Crossref
Crossref
Ximena Vergara, Gabor Mezei & Leeka Kheifets. (2014) Case-control study of occupational exposure to electric shocks and magnetic fields and mortality from amyotrophic lateral sclerosis in the US, 1991–1999. Journal of Exposure Science & Environmental Epidemiology 25:1, pages 65-71.
Crossref
Crossref
Stefan Kölker, Dries Dobbelaere, Johannes Häberle, Peter Burgard, Florian Gleich, Marshall L. Summar, Steven Hannigan, Samantha Parker, Anupam Chakrapani & Matthias R. Baumgartner. 2015. JIMD Reports, Volume 22. JIMD Reports, Volume 22
29
38
.
Oleguer Parés-Badell, Gabriela Barbaglia, Petra Jerinic, Anders Gustavsson, Luis Salvador-Carulla & Jordi Alonso. (2014) Cost of Disorders of the Brain in Spain. PLoS ONE 9:8, pages e105471.
Crossref
Crossref
Jane Larkindale, Wenya Yang, Paul F. Hogan, Carol J. Simon, Yiduo Zhang, Anjali Jain, Elizabeth M. Habeeb-Louks, Annie Kennedy & Valerie A. Cwik. (2014) Cost of illness for neuromuscular diseases in the United States. Muscle & Nerve 49:3, pages 431-438.
Crossref
Crossref
C.R. Sánchez-López, L. Perestelo-Pérez, C. Ramos-Pérez, J. López-Bastida & P. Serrano-Aguilar. (2014) Health-related quality of life in patients with amyotrophic lateral sclerosis. Neurología (English Edition) 29:1, pages 27-35.
Crossref
Crossref
C.R. Sánchez-López, L. Perestelo-Pérez, C. Ramos-Pérez, J. López-Bastida & P. Serrano-Aguilar. (2014) Calidad de vida relacionada con la salud en pacientes con esclerosis lateral amiotrófica. Neurología 29:1, pages 27-35.
Crossref
Crossref
Poul Jennum, Rikke Ibsen, Stephen Wørlich Pedersen & Jakob Kjellberg. (2012) Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study. Journal of Neurology 260:3, pages 785-793.
Crossref
Crossref
Renata Linertová, Pedro Serrano-Aguilar, Manuel Posada-de-la-Paz, Manuel Hens-Pérez, Panos Kanavos, Domenica Taruscio, Arrigo Schieppati, Rumen Stefanov, Márta Péntek, Claudia Delgado, Johann-Matthias Graf von der Schulenburg, Ulf Persson, Karine Chevreul, Giovanni Fattore, Melany Worbes-Cerezo, Mark Sefton & Julio López-Bastida. (2012) Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study. Health Policy 108:1, pages 19-26.
Crossref
Crossref
Geraldine Foley, Virpi Timonen & Orla Hardiman. (2011) Experience of Services as a Key Outcome in Amyotrophic Lateral Sclerosis (ALS) Care. American Journal of Hospice and Palliative Medicine® 29:5, pages 362-367.
Crossref
Crossref
Ted M. Burns, Christopher D. Graham, Michael R. Rose & Zachary Simmons. (2012) Quality of life and measures of quality of life in patients with neuromuscular disorders. Muscle & Nerve 46:1, pages 9-25.
Crossref
Crossref
Myoung Soo KimHyung-Ik ShinYusun MinJung Yoon KimJung Soon Kim. (2011) Correlation between Severe ALS Patient-Caregiver Couples' Characteristics and Caregivers' Health Related Quality of Life. Journal of Korean Academy of Nursing 41:3, pages 354.
Crossref
Crossref
Julio López-Bastida & Juan Oliva-Moreno. 2010. Rare Diseases Epidemiology. Rare Diseases Epidemiology
273
282
.
Luis Rajmil, Lilisbeth Perestelo-Pérez & Michael Herdman. 2010. Rare Diseases Epidemiology. Rare Diseases Epidemiology
251
272
.